Burden of laboratory-confirmed Campylobacter infections in Guatemala 2008–2012: Results from a facility-based surveillance system
Supporting Files
-
2014 ; 3-2014
-
Available in CDC Stacks on 2015-12-01T00:00:00Z
File Language:
English
Details
-
Alternative Title:J Epidemiol Glob Health
-
Personal Author:
-
Description:Introduction ; Campylobacteriosis is one of the leading causes of gastroenteritis worldwide. This study describes the epidemiology of laboratory-confirmed Campylobacter diarrheal infections in two facility-based surveillance sites in Guatemala. ; Methods ; Clinical, epidemiologic, and laboratory data were collected on patients presenting with acute diarrhea from select healthcare facilities in the departments of Santa Rosa and Quetzaltenango, Guatemala, from January 2008 through August 2012. Stool specimens were cultured for Campylobacter and antimicrobial susceptibility testing was performed on a subset of isolates. Multidrug resistance (MDR) was defined as resistance to ≥3 antimicrobial classes. ; Results ; Campylobacter was isolated from 306 (6.0%) of 5137 stool specimens collected. For children <5 years of age, annual incidence was as high as 1288.8 per 100,000 children in Santa Rosa and 185.5 per 100,000 children in Quetzaltenango. Among 224 ambulatory care patients with Campylobacter, 169 (75.5%) received metronidazole or trimethoprim-sulfamethoxazole, and 152 (66.7%) received or were prescribed oral rehydration therapy. Antimicrobial susceptibilities were tested in 96 isolates; 57 (59.4%) were resistant to ciprofloxacin and 12 (12.5%) were MDR. ; Conclusion ; Campylobacter was a major cause of diarrhea in children in two departments in Guatemala; antimicrobial resistance was high, and treatment regimens in the ambulatory setting which included metronidazole and trimethoprim-sulfamethoxazole and lacked oral rehydration were sub-optimal.
-
Subjects:
- Adolescent
- Adult
- Ambulatory Care Facilities
- Anti-Bacterial Agents
- Campylobacter
- Campylobacter Infections
- Child
- Child, Preschool
- Ciprofloxacin
- Communicable Disease Control
- Cost of Illness
- Diarrhea
- Drug Resistance, Multiple, Bacterial
- Feces
- Female
- Fluid Therapy
- Guatemala
- Humans
- Infant
- Infant, Newborn
- Male
- Metronidazole
- Microbial Sensitivity Tests
- Middle Aged
- Rehydration Solutions
- Sentinel Surveillance
- Trimethoprim, Sulfamethoxazole Drug Combination
- Young Adult
-
Keywords:
-
Source:J Epidemiol Glob Health. 4(1):51-59
-
Pubmed ID:24534336
-
Pubmed Central ID:PMC4666523
-
Document Type:
-
Funding:
-
Volume:4
-
Issue:1
-
Download URL:
-
File Type:
-
Collection(s):
-
Main Document Checksum:urn:sha256:87017e222c29122a72fc16e3dc933914baf55ca0889665cdfefff8d3788a5572
Supporting Files
File Language:
English
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings, journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like
COLLECTION
CDC Public Access